Rachel Scott, PharmD

Articles by Rachel Scott, PharmD

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

ByJesen Fagerness, JD,Eileen Fonseca, MS,Gregory P. Hess, MD, MBA, MSc,Rachel Scott, PharmD,Kathryn R. Gardner, MS,Michael Koffler, MBA,Maurizio Fava, MD,Roy H. Perlis, MD, MSc,Francis X. Brennan, PhD,Jay Lombard, DO

May 20th 2014

Pharmacy and medical claims data showed that patients whose clinicians had access to pharmacogenetic test results had increased adherence and overall cost savings.

Latest Updated Articles

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings
Published: May 20th 2014 | Updated:

Rachel Scott, PharmD

Articles by Rachel Scott, PharmD

Pharmacogenetic-Guided Psychiatric Intervention Associated With Increased Adherence and Cost Savings

Latest Updated Articles

Trending on AJMC

Advances in MASLD and MASH Care Highlight Progress and Persistent Gaps

Patients With Long-Term Conditions Prefer Remote Visits for Routine Care

New Legislation Aims to Address Transparency in PBMs as First Major Step in Reform

Employer Premiums and Deductibles Consume Significant Portion of Income in 19 States

Scaling Innovation in Advanced Multiple Myeloma Care Delivery: A Q&A With Ameet Patel, MD